FDA Approves Striverdi Respimat to Treat Chronic Obstructive Pulmonary Disease

August 3, 2014 3:56 PM

20 0

The FDA approved a new inhalation spray called Striverdi Respimat to treat patients with chronic obstructive pulmonary disease (COPD).

In a latest announcement, the U.S. Food and Drug Administration approved Olodaterol (Striverdi Respimat), an inhalation spray that is meant to treat those with COPD including those with chronic bronchitis and/or emphysema that are experiencing airflow obstruction. The newly approved drug can be used...

Read more

To category page